#BREAKING Brexit bill clears UK parliament, set to become law pic.twitter.com/rRbDbnnbQl
— AFP News Agency (@AFP) January 22, 2020
Innate Pharma Announced That Sanofi Has Made Decision to Progress IPH6401/SAR’514 Into Investigational New Drug-enabling Studies, Triggering €3M Milestone Payment
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that Sanofi has made the decision to progress IPH6401/SAR'514 into investigational new drug (IND)-enabling studies, triggering a €3 million milestone payment.
